Department of Physiology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an, China.
Crit Care Med. 2013 Jun;41(6):e74-84. doi: 10.1097/CCM.0b013e318278b6e7.
Clinical evidence indicates that intensive insulin treatment prevents the incidence of multiple organ failures in surgical operation and severe trauma, but the mechanisms involved remain elusive. This study was designed to test the hypothesis that insulin may exert anti-inflammatory and antioxidative effects and thus alleviate cardiac dysfunction after trauma.
Prospective, randomized experimental study.
Animal research laboratory.
Sprague Dawley rats.
Anesthetized rats were subjected to 200 revolutions at a rate of 35 rpm in Noble-Collip drum to induce a nonlethal mechanical trauma and were randomized to receive vehicle, insulin, and insulin + wortmannin treatments. An in vitro study was performed on cultured cardiomyocytes subjected to sham-traumatic serum (SS), traumatic serum (TS), SS + tumor necrosis factor (TNF)-α, SS + H2O2, TS + neutralizing anti-TNF-α antibody, or TS + tempol treatments.
Immediate cardiac dysfunction occurred 0.5 hr after trauma without significant cardiomyocyte necrosis and apoptosis, while serum TNF-α and cardiac reactive oxygen species (ROS) production was increased. Importantly, incubation of cardiomyocytes with TS or SS + TNF-α significantly increased ROS generation together with dampened cardiomyocyte contractility and Ca transient, all of which were rescued by TNF-α antibody. Administration of insulin inhibited TNF-α and ROS overproduction and alleviated cardiac dysfunction 2 hours after trauma. Scavenging ROS with tempol also attenuated cardiac dysfunction after trauma, whereas insulin combined with tempol failed to further improve cardiac functional recovery compared with insulin treatment alone. Moreover, the aforementioned anti-TNF-α, antioxidative, and cardioprotective effects afforded by insulin were almost abolished by the phosphatidylinositol 3-kinase inhibitor wortmannin.
These results demonstrate for the first time that mechanical trauma induces a significant increase in TNF-α and ROS production, resulting in immediate cardiac dysfunction. Early posttrauma insulin treatment alleviates cardiac dysfunction by inhibiting TNF-α-mediated ROS production via a phosphatidylinositol 3-kinase/Akt-dependent mechanism.
临床证据表明,强化胰岛素治疗可预防手术和严重创伤中的多器官衰竭的发生,但涉及的机制仍不清楚。本研究旨在验证胰岛素可能发挥抗炎和抗氧化作用,从而减轻创伤后心脏功能障碍的假说。
前瞻性、随机实验研究。
动物研究实验室。
Sprague Dawley 大鼠。
麻醉大鼠在 Noble-Collip 滚筒中以 35rpm 的速度旋转 200 转,以诱导非致死性机械创伤,并随机接受载体、胰岛素和胰岛素+wortmannin 治疗。对培养的心肌细胞进行了体外研究,使其经历假创伤血清(SS)、创伤血清(TS)、SS+肿瘤坏死因子(TNF)-α、SS+H2O2、TS+中和抗 TNF-α 抗体或 TS+tempol 处理。
创伤后 0.5 小时即刻出现心脏功能障碍,而无明显的心肌细胞坏死和凋亡,但血清 TNF-α和心脏活性氧(ROS)产生增加。重要的是,TS 或 SS+TNF-α孵育显著增加 ROS 生成,同时降低心肌细胞收缩力和 Ca 瞬变,所有这些都可被 TNF-α 抗体挽救。胰岛素给药可抑制 TNF-α和 ROS 的过度产生,并在创伤后 2 小时缓解心脏功能障碍。使用 tempol 清除 ROS 也可减轻创伤后心脏功能障碍,而与单独使用胰岛素治疗相比,胰岛素联合 tempol 治疗并不能进一步改善心脏功能恢复。此外,胰岛素提供的上述抗 TNF-α、抗氧化和心脏保护作用几乎被磷脂酰肌醇 3-激酶抑制剂 wortmannin 所消除。
这些结果首次表明,机械创伤导致 TNF-α和 ROS 产生显著增加,从而导致即刻的心脏功能障碍。创伤后早期给予胰岛素治疗可通过抑制 TNF-α 介导的 ROS 产生来缓解心脏功能障碍,其机制与磷脂酰肌醇 3-激酶/Akt 依赖性机制有关。